Table 2.
Test results in comparison with other previously published data.
| Haptens | Lithuania 2014–2016 | Lithuania 2010–2012 [4] | Sweden 2010–2012 [4] | The European baseline series in 10 European countries 2005-2006 [5] |
Korea 2004–2011 [6] | European multicentre study [7] | |||
|---|---|---|---|---|---|---|---|---|---|
| Western (United Kingdom) | Southern (Spain, Italy) | Central (Netherlands, Switzerland, Austria, Germany) | Northeast (Finland, Lithuania, Poland) | ||||||
| % (n/N) | % (n/N) | % (n/N) | % (n/N) | % (n/N) | % (n/N) | % (n/N) | % (n/N) | % (n/N) | |
| Nickel sulphate | 29.6 (149/504) | 25.7 (55/214) | 18.9 (81/428) | 20.8 (1752/8468) | 24.5 (660/2666) | 19.7 (1056/5708) | 22.4 (348/1585) | 25.0 (11/44)& | 25.2 (228/906)& |
| Cobalt(II) chloride hexahydrate | 8.7 (44/504) | 7.5 (16/214) | 6.3 (27/428) | 6.2 (522/8498) | 6.8 (178/2616) | 7.2 (398/5730) | 8.8 (137/1596) | 15.9 (7/44)& | — |
| Potassium dichromate | 6.6 (33/504) | 6.1 (13/214) | 2.8 (12/428) | 2.4 (211/8537) | 4.5 (119/2666) | 5.9 (347/5737) | 5.3 (86/1606) | 22.7 (10/44)& | — |
| Gold(I) sodium thiosulphate | 35.6 (31/87)& | 23.8∧ | 13.6∧ | — | — | — | — | 25.0 (11/44)& | — |
| Palladium(II) chloride | 14.9 (13/87)& | — | — | — | — | — | — | 6.8 (3/44)& | 24.3 (220/906)& |
n: positive test reactions.
N: total tests.
&Population tested with dental screening or metal series.
∧Consecutive patients tested with European baseline series with added gold(I) sodium thiosulphate.